With promising new obesity treatments in the pipeline, 24/7 Wall St. projects healthy upside for Novo Nordisk stock through ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Pens for the diabetes drug Ozempic sit on a production line to be packaged at the Danish drugmaker Novo Nordisk's site ...
The choice isn't that hard.
Barchart on MSN
The new Wegovy pill is already popular. Does that make Novo Nordisk stock a buy for Q1?
Novo Nordisk A/S (NVO) kicked off 2026 with a major milestone: the U.S. launch of the Wegovy weight-loss pill. This marks the first oral GLP-1 therapy, which was approved by the Food and Drug ...
Wegovy injection pens. Novo Nordisk’s near-term focus is to launch a pill form of the weight-loss drug. (Dhiraj Singh/Bloomberg News) After losing out to Pfizer for a weight-loss drug startup, Novo ...
Novo Nordisk's new indications for semaglutide and its attractive pipeline could allow it to bounce back. Intuitive Surgical should remain the leader in its niche despite increased competition. Both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results